Dec 11, 2017 13:00 pm UTC| Business
Phoenix, AZ, Dec. 11, 2017 -- Uptick Newswire, the sole producer of the Uptick Network “Stock Day” Podcast, is keeping investors and shareholders up-to-date on company news and bringing transparency to the micro-cap...
NEP Studios Expands Offerings in Midtown Manhattan
Dec 11, 2017 13:00 pm UTC| Business
NEW YORK, Dec. 11, 2017 -- NEP Studios, a division of NEP Group, Inc., the global leader of outsourced broadcast and live event production solutions, announced today it will expand its lineup of studio facilities...
Dec 11, 2017 13:00 pm UTC| Business
MENLO PARK, Calif., Dec. 11, 2017 -- TeneoBio, Inc. yesterday presented preclinical data on its lead therapeutic candidate, TNB-383B, a multivalent anti-BCMAxCD3 at the American Society of Hematology annual meeting in...
Dec 11, 2017 13:00 pm UTC| Business
145 Patients to be enrolledData expected in the second quarter of 2018Study will be fully-funded by BARDA GAITHERSBURG, Md., Dec. 11, 2017 -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company,...
Dec 11, 2017 12:56 pm UTC| Business
IRVINE, CA, Dec. 11, 2017 -- Cannabis Science, Inc. (OTC Pink: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, announces the signing of a Collaboration Research Agreement...
Global Machine to Machine (M2M) Market Will Reach USD 25.24 Billion by 2022: Zion Market Research
Dec 11, 2017 12:54 pm UTC| Business
Sarasota, FL, Dec. 11, 2017 -- Zion Market Research has published a new report titled “Mobile Advertising Market by Types (Display Advertising, In-App Advertising, In-Game Advertising, Search Advertising and Others) for...
Dec 11, 2017 12:45 pm UTC| Business
PHILADELPHIA, Dec. 11, 2017 -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced that it has dosed seven...
China's Economic Resurgence: Strong Growth Signals a Bright Future Ahead
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update